BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Advice not to use Novabel® any more, Merz

Product group Non-active implants
Reference 02363/10

Merz informs about an advice not to use Novabel® any more due to reported adverse reactions until they can provide treatment protocols. Merz asks for continued diligence in monitoring patients previously injected with Novabel®.

.

Advice not to use Novabel® any more, Merz , Download_VeroeffentlichtAm_EN PDF, 79KB, File is accessible

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK